Astellas Pharma Inc. (ALPMY)
OTC: ALPMY
· Real-Time Price · USD
11.51
0.14 (1.23%)
At close: Aug 19, 2025, 3:58 PM
11.51
0.00%
After-hours: Aug 19, 2025, 03:49 PM EDT
Astellas Pharma Revenue
Astellas Pharma reported an annual revenue of $1,912.3B, reflecting a 19.25% growth. For the quarter ending March 31, 2025, Astellas Pharma generated $459.29B in revenue.
Revenue (ttm)
1,912.3B
Revenue Growth
19.25%
Price / Sales Ratio
1.36
Revenue / Employee
129.61M
Employees
14,754
Market Cap
20.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Mar 31, 2025 | 1,912.3B | +19.25% |
| Mar 31, 2024 | 1,603.7B | +5.60% |
| Mar 31, 2023 | 1,518.6B | +17.16% |
| Mar 31, 2022 | 1,296.2B | +3.73% |
| Mar 31, 2021 | 1,249.5B | -3.94% |
| Mar 31, 2020 | 1,300.8B | -0.42% |
| Mar 31, 2019 | 1,306.3B | +0.46% |
| Mar 31, 2018 | 1,300.3B | -0.87% |
| Mar 31, 2017 | 1,311.7B | -4.45% |
| Mar 31, 2016 | 1,372.7B | +10.06% |
| Mar 31, 2015 | 1,247.3B | +9.42% |
| Mar 31, 2014 | 1,139.9B | +13.35% |
| Mar 31, 2013 | 1,005.6B | n/a |